|
Form Serial Number: |
DA20240516E00001
|
1.
Date of relevant event: |
03/05/2024 (dd/mm/yyyy)
|
2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
3.
Stock code: |
01801 |
4.
Name of listed corporation: |
Innovent Biologics, Inc. |
5.
Class of shares: |
Ordinary Shares |
6.
Number of issued shares in class: |
1,627,101,801 |
7.
Name of director (English) as printed on HKID Card/Passport: |
(Surname) |
Zhang |
(Other names) |
Qian |
|
|
|
10.
Name of director (Chinese): |
張倩 |
11.
Chinese Character Code as printed on HKID Card: |
|
|
24.
Details of relevant event: |
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
Long position |
1705 | Miscellaneous Notice filed because you became a director or chief executive of the listed corporation | |
|
|
6,388,829 |
|
|
|
|
|
Short position |
|
|
|
|
|
|
|
|
|
|
|
25.
Total shares in listed corporation immediately before the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 6,388,829 | 0.39 |
|
|
26.
Total shares in listed corporation immediately after the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 6,388,829 | 0.39 |
|
|
27.
Capacity in which interests disclosed in Box 26 are held: |
Code describing capacity | Number of shares |
| |
|
|
28.
Further information in derivative interests in listed corporation : |
Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
Long position | 4105 | Unlisted derivatives - Physically settled |
| | | HKD | 0 | | | | | 756,500 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 22/03/2024 | 22/03/2034 | HKD | 1 | HKD | 40.240 | | | 267,000 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| | | HKD | 0 | | | | | 670,000 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 30/03/2023 | 30/03/2033 | HKD | 1 | HKD | 38.390 | | | 440,000 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| | | HKD | 0 | | | | | 560,644 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 30/03/2022 | 30/03/2032 | HKD | 1 | HKD | 30.600 | | | 373,763 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| | | HKD | 0 | | | | | 40,000 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 30/03/2021 | 30/03/2031 | HKD | 1 | HKD | 78.200 | | | 342,857 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 15/04/2020 | 15/04/2030 | HKD | 1 | HKD | 33.950 | | | 685,714 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 15/03/2019 | 15/03/2029 | HKD | 1 | HKD | 28.300 | | | 542,857 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 13/07/2018 | 13/07/2028 | HKD | 1 | HKD | 1.664 | | | 200,000 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 13/04/2018 | 13/04/2028 | HKD | 1 | HKD | 1.554 | | | 1,000,000 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 15/09/2017 | 15/09/2027 | HKD | 1 | HKD | 1.547 | | | 125,000 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 14/04/2017 | 14/04/2027 | HKD | 1 | HKD | 1.539 | | | 50,000 |
|
|
29.
Further information in relation to interests of children under 18 and/or spouse: |
Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
|
30.
Further information in relation to interests of corporations controlled by Director: |
Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| | | | | |
|
|
31.
Further information in relation to interests held by Director jointly with another person: |
Name of joint shareholder | Address | Number of shares |
| | |
|
|
32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
Names of Trust | Address | Status code | Number of shares |
| | | |
|
|
33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
Names of other parties | Address | Number of shares |
| | |
Total number of shares in which a director is interested under sections 317 and 318 | |
|
|
34.
Supplementary information: |
In Box 24, the 6,388,829 shares include (1) a sum of 4,027,191 shares to be subscribed upon full exercise of the options granted by the Company, and (2) a sum of 2,027,144 shares to be issued upon full vesting of the restricted shares granted by the Company, please see Box 28 for details.
|
35.
Log/Serial Number of the previous form: |
|
36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
Date of filing this Form 3A: |
16/05/2024 (dd/mm/yyyy)
|
|